Experimental peptides are gaining attention across the United States as consumers seek new treatments for weight loss, recovery and longevity. However, limited human clinical evidence and changing FDA regulations present difficult questions for healthcare providers. Recent reporting and physician surveys reveal a growing divide between consumer demand and established medical standards.